• British dental journal · Jan 1996

    Dentists practising in Lothian treat HIV seropositive patients: is this a resolution of conflict or a case of Hobson's choice?

    • B J Gibson and R Freeman.
    • Division of Paediatric and Preventive Dentistry, Queen's University of Belfast.
    • Br Dent J. 1996 Jan 20; 180 (2): 53-6.

    AbstractDentists are now required to treat HIV-positive patients in their practices. Dentists working in high HIV prevalence areas treat HIV seropositive patients but what affects this treatment decision? The aim of this study is to investigate the role of conflict with regard to treatment decisions. All 371 dentists practising in Lothian were sent a questionnaire. Two hundred and fifteen questionnaires were returned giving a valid response rate of 60%. The findings of this study would support the view that dentists are able to use their scientific knowledge which reduces anxieties and assists in the resolution of their conflict with regard to the treatment of HIV seropositive patients.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.